Fed. Circ. Backs Fresenius Win Over Hospira Sedative Patent
The Federal Circuit on Thursday upheld an Illinois federal court decision invalidating Hospira Inc.'s patent for the sedation drug Precedex, paving the way for Fresenius Kabi USA LLC to move forward...To view the full article, register now.
Already a subscriber? Click here to view full article